Literature DB >> 28349192

[Interstitial processes of the lungs in childhood].

H Popper1.   

Abstract

Interstitial processes in the lungs of children can be due to several underlying diseases. Knowledge of the child's age is important as genetic aberrations play a major role in diseases in the first 2 years, whereas immunological diseases are more common starting in kindergarden age. In general lung diseases are rare in children, which makes the diagnostics difficult and results in a delayed diagnosis. In addition, pediatric pulmonologists are often very reluctant to perform lung biopsies due to a lack of a specialized pathologist. In order to make a contribution to the diagnostics of pediatric pulmonary diseases, pathologists should be specialized in pulmonary pathology, have a good knowledge of genetic methods and fetal lung development, which includes the genetic factors involved in lung growth and differentiation. A close cooperation with the pediatric pulmonologist is necessary and each patient should be discussed jointly on an interstitial lung disease board to promote the quality of diagnostics. The pathologist should be aware that the developing lungs of children are not just a smaller form of adult lungs and often react very differently. In this article, we mainly focus on diffuse infiltration patterns, such as ground glass and reticulonodular infiltrations as described in high-resolution computed tomography (HRCT). Localized interstitial processes, which can sometimes be tumor-like and malformations are not dealt with; however, vascular malformations are included as these often manifest as diffuse interstitial infiltrations and must therefore be taken into consideration for the differential diagnostics.

Entities:  

Keywords:  Diffuse infiltrations; Genetic alterations; Immunological diseases; Infections; Vascular malformations

Mesh:

Substances:

Year:  2017        PMID: 28349192     DOI: 10.1007/s00292-017-0280-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  80 in total

Review 1.  Systemic diseases and the lung.

Authors:  Robert Dinwiddie; Samatha Sonnappa
Journal:  Paediatr Respir Rev       Date:  2005-09       Impact factor: 2.726

2.  Familial idiopathic interstitial pneumonia: histopathology and survival in 30 patients.

Authors:  Kevin O Leslie; Carlyne D Cool; Thomas A Sporn; Douglas Curran-Everett; Mark P Steele; Kevin K Brown; Momen M Wahidi; David A Schwartz
Journal:  Arch Pathol Lab Med       Date:  2012-11       Impact factor: 5.534

3.  16q24.1 microdeletion in a premature newborn: usefulness of array-based comparative genomic hybridization in persistent pulmonary hypertension of the newborn.

Authors:  Flore Zufferey; Danielle Martinet; Maria-Chiara Osterheld; Florence Niel-Bütschi; Eric Giannoni; Nathalie Besuchet Schmutz; Zhilian Xia; Jacques S Beckmann; Charles Shaw-Smith; Pawel Stankiewicz; Claire Langston; Florence Fellmann
Journal:  Pediatr Crit Care Med       Date:  2011-11       Impact factor: 3.624

4.  Pulmonary veno-occlusive disease.

Authors:  C B Carrington; A A Liebow
Journal:  Hum Pathol       Date:  1970-06       Impact factor: 3.466

5.  Mesodermal Pten inactivation leads to alveolar capillary dysplasia- like phenotype.

Authors:  Caterina Tiozzo; Gianni Carraro; Denise Al Alam; Sheryl Baptista; Soula Danopoulos; Aimin Li; Maria Lavarreda-Pearce; Changgong Li; Stijn De Langhe; Belinda Chan; Zea Borok; Saverio Bellusci; Parviz Minoo
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

6.  Haploinsufficiencies of FOXF1 and FOXC2 genes associated with lethal alveolar capillary dysplasia and congenital heart disease.

Authors:  Shihui Yu; Lei Shao; Howard Kilbride; David L Zwick
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

7.  The silent codon change I507-ATC->ATT contributes to the severity of the ΔF508 CFTR channel dysfunction.

Authors:  Ahmed Lazrak; Lianwu Fu; Vedrana Bali; Rafal Bartoszewski; Andras Rab; Viktoria Havasi; Steve Keiles; John Kappes; Ranjit Kumar; Elliot Lefkowitz; Eric J Sorscher; Sadis Matalon; James F Collawn; Zsuzsanna Bebok
Journal:  FASEB J       Date:  2013-08-01       Impact factor: 5.191

8.  Diffuse pulmonary lymphangiomatosis.

Authors:  H D Tazelaar; D Kerr; S A Yousem; M J Saldana; C Langston; T V Colby
Journal:  Hum Pathol       Date:  1993-12       Impact factor: 3.466

9.  Histologic resolution of pulmonary interstitial glycogenosis.

Authors:  Gail H Deutsch; Lisa R Young
Journal:  Pediatr Dev Pathol       Date:  2009 Nov-Dec

10.  Novel CFTR variants identified during the first 3 years of cystic fibrosis newborn screening in California.

Authors:  Lisa Prach; Ruth Koepke; Martin Kharrazi; Steven Keiles; Danieli B Salinas; Maria Carmen Reyes; Mark Pian; Harry Opsimos; Kimberly N Otsuka; Karen Ann Hardy; Carlos E Milla; Jacquelyn M Zirbes; Bradley Chipps; Susan O'Bra; Muhammad M Saeed; Reddivalam Sudhakar; Susan Lehto; Dennis Nielson; Gregory F Shay; Mary Seastrand; Sanjay Jhawar; Bruce Nickerson; Christopher Landon; Ann Thompson; Eliezer Nussbaum; Terry Chin; Henry Wojtczak
Journal:  J Mol Diagn       Date:  2013-06-28       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.